Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
- Conditions
- Lupus Erythematosus
- Interventions
- Other: The Morisky Medication Adherence Scale
- Registration Number
- NCT06161363
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.
The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Age >18 years
- Patient with systemic lupus erythematosus
- Treatment with PLAQUENIL for > 6 months with dosage of hydroxychloroquinemia planned during the consultation.
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description The Morisky Medication Adherence Scale (MMAS-8) The Morisky Medication Adherence Scale The Morisky Medication Adherence Scale completed by the patients
- Primary Outcome Measures
Name Time Method Non-compliance with hydroxychloroquine treatment Day 0 to describe the non-compliance with hydroxychloroquine treatment with the Morisky Medication Adherence Scale
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Toulouse Hospital
🇫🇷Toulouse, France